311 related articles for article (PubMed ID: 22525352)
1. Make way for the 'next generation': application and prospects for genome-wide, epigenome-specific technologies in endocrine research.
Emes RD; Farrell WE
J Mol Endocrinol; 2012 Aug; 49(1):R19-27. PubMed ID: 22525352
[TBL] [Abstract][Full Text] [Related]
2. Studying the epigenome using next generation sequencing.
Ku CS; Naidoo N; Wu M; Soong R
J Med Genet; 2011 Nov; 48(11):721-30. PubMed ID: 21825079
[TBL] [Abstract][Full Text] [Related]
3. Introduction into the analysis of high-throughput-sequencing based epigenome data.
Huss M
Brief Bioinform; 2010 Sep; 11(5):512-23. PubMed ID: 20457755
[TBL] [Abstract][Full Text] [Related]
4. Epigenome sequencing comes of age in development, differentiation and disease mechanism research.
Zhao Q; Zhang Y
Epigenomics; 2011 Apr; 3(2):207-20. PubMed ID: 22122282
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic profiling of cancer cells.
Gargiulo G; Minucci S
Int J Biochem Cell Biol; 2009 Jan; 41(1):127-35. PubMed ID: 18771747
[TBL] [Abstract][Full Text] [Related]
6. Single-molecule, genome-scale analyses of DNA modifications: exposing the epigenome with next-generation technologies.
Zillner K; Németh A
Epigenomics; 2012 Aug; 4(4):403-14. PubMed ID: 22920180
[TBL] [Abstract][Full Text] [Related]
7. Introduction to epigenomics and epigenome-wide analysis.
Fazzari MJ; Greally JM
Methods Mol Biol; 2010; 620():243-65. PubMed ID: 20652507
[TBL] [Abstract][Full Text] [Related]
8. The impact of epigenomics on future drug design and new therapies.
Hamm CA; Costa FF
Drug Discov Today; 2011 Jul; 16(13-14):626-35. PubMed ID: 21570477
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumours: all silent on the epigenetics front.
Dudley KJ; Revill K; Clayton RN; Farrell WE
J Mol Endocrinol; 2009 Jun; 42(6):461-8. PubMed ID: 19208779
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.
Björkman M; Rantala J; Nees M; Kallioniemi O
Epigenomics; 2010 Oct; 2(5):683-9. PubMed ID: 22122051
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic biomarkers: A new perspective in laboratory diagnostics.
García-Giménez JL; Sanchis-Gomar F; Lippi G; Mena S; Ivars D; Gomez-Cabrera MC; Viña J; Pallardó FV
Clin Chim Acta; 2012 Oct; 413(19-20):1576-82. PubMed ID: 22664147
[TBL] [Abstract][Full Text] [Related]
12. Next-generation technologies and data analytical approaches for epigenomics.
Mensaert K; Denil S; Trooskens G; Van Criekinge W; Thas O; De Meyer T
Environ Mol Mutagen; 2014 Apr; 55(3):155-70. PubMed ID: 24327356
[TBL] [Abstract][Full Text] [Related]
13. [Epigenome and human disease].
Ushijima T; Katsurano M; Asada K
Nihon Rinsho; 2009 Jun; 67(6):1219-26. PubMed ID: 19507518
[TBL] [Abstract][Full Text] [Related]
14. Cancer epigenome.
Lechner M; Boshoff C; Beck S
Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation.
Brennan K; Flanagan JM
Methods Mol Biol; 2012; 863():439-65. PubMed ID: 22359310
[TBL] [Abstract][Full Text] [Related]
16. Microarray for epigenetic changes: gene expression arrays.
Colyer HA; Armstrong RN; Mills KI
Methods Mol Biol; 2012; 863():319-28. PubMed ID: 22359303
[TBL] [Abstract][Full Text] [Related]
17. The next innovation cycle in toxicogenomics: environmental epigenetics.
Reamon-Buettner SM; Mutschler V; Borlak J
Mutat Res; 2008; 659(1-2):158-65. PubMed ID: 18342568
[TBL] [Abstract][Full Text] [Related]
18. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.
Schweiger MR; Kerick M; Timmermann B; Isau M
Cancer Metastasis Rev; 2011 Jun; 30(2):199-210. PubMed ID: 21267768
[TBL] [Abstract][Full Text] [Related]
19. Techniques to study epigenetic control and the epigenome in parasites.
Nardelli SC; Ting LM; Kim K
Methods Mol Biol; 2015; 1201():177-91. PubMed ID: 25388114
[TBL] [Abstract][Full Text] [Related]
20. The USC Epigenome Center.
Laird PW
Epigenomics; 2009 Oct; 1(1):29-31. PubMed ID: 22122635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
